AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Tofajak-IN XR 11mg Tablet

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Tofacitinib (11mg)

Overview Tofajak-IN XR 11mg Tablet

Extended-release Tofajak-IN 11mg tablets are indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication alleviates joint pain, tenderness, and swelling by suppressing inflammation and hindering the progression of bone and joint deterioration. It may be administered alone or in conjunction with other medications. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your health status and other concurrent medications, strictly following your physician's instructions. Discontinuation should only occur under medical supervision to prevent disease exacerbation. Common side effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse reactions such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Consult your doctor concerning any side effect concerns. Pre-treatment bloodwork may be required, and initiation is contraindicated in the presence of infection. Prior to treatment, disclose any history of tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Tofajak-IN 11mg XR can increase susceptibility to infections or worsen existing ones; minimize contact with individuals suffering from contagious illnesses (e.g., varicella, rubeola, influenza). This medication is not approved for use in individuals under 18 years of age, and is contraindicated during pregnancy and breastfeeding unless deemed medically necessary. Regular medical monitoring may be required.

Primary Ingredients of Tofajak-IN XR 11mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Tofajak-IN XR 11mg Tablet

Management of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.

Major Benefits of Tofajak-IN XR 11mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Tofajak-IN XR 11mg Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Tofajak-IN XR 11mg Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Tofajak-IN XR 11mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tofajak-IN XR 11mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistent timing is recommended.

How Tofajak-IN XR 11mg Tablet works:

Tofajak-IN XR 11mg tablets contain a Janus kinase inhibitor that suppresses Janus kinase enzyme activity. This reduces immune system activity and inflammation characteristic of rheumatic diseases and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Tofajak-IN XR 11mg Tablet and alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Tofajak 11mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release tofacitinib (11mg) tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Tofajak-IN XR 11mg Tablets.

KidneyKidneyCAUTION

Extended-release Tofajak-IN 11mg tablets require careful administration for individuals with advanced kidney impairment. Dosage modification of Tofajak-IN 11mg extended-release tablets may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Extended-release Tofajak-IN 11mg tablets require careful administration for individuals with advanced hepatic impairment. Dosage modification of Tofajak-IN 11mg extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Tofajak-IN XR 11mg Tablet :

Should you forget a Tofajak-IN XR 11mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tofajak-IN XR 11mg Tablet

LabelValue
Chemical Type Pyrrolopyrimidine Analog
Developing Habits No.
Treatment Category Pain Relievers
Action Class JAK inhibitors

FAQs on Tofajak-IN XR 11mg Tablet

Tell your doctor about any liver problems before starting Tofajak-IN XR 11mg Tablets. This medication may increase liver enzymes in some individuals, so your liver function should be assessed beforehand. While Tofajak-IN XR 11mg Tablets can be used in patients with mild to moderate liver impairment, it's contraindicated in those with severe impairment.
Taking Tofajak-IN XR 11mg tablets may raise your risk of certain cancers, such as lymphoma and skin cancer, due to its effects on the immune system. Tell your doctor if you have or have had any type of cancer.
Tofajak-IN XR 11mg tablets treat moderate to severe rheumatoid arthritis, a joint inflammatory disease. This medication is prescribed when previous treatments proved ineffective or unsuitable. It may also be used earlier if initial drug therapies fail, either alone or in combination with other medications like methotrexate.
You may not feel the full benefits of Tofajak-IN XR 11mg Tablet for 3 to 6 months, though some improvement may be noticed within 2 to 8 weeks.
Before and during treatment with Tofajak-IN XR 11mg Tablet, blood tests may be necessary to monitor for anemia, neutropenia, lymphopenia, high cholesterol, and elevated liver enzymes. These tests help ensure the medication isn't causing adverse effects. Your doctor might also recommend a tuberculosis test beforehand, as Tofajak-IN XR 11mg Tablet could worsen an existing infection.
Tofajak-IN XR 11mg Tablets suppress the immune system, potentially increasing susceptibility to serious infections, including tuberculosis and disseminated fungal, bacterial, or viral infections. These infections can be life-threatening and require hospitalization.
Taking Tofajak-IN XR 11mg Tablet with tocilizumab is not recommended. Because Tofajak-IN XR 11mg Tablet weakens the immune system, combining it with other immunosuppressants, such as tocilizumab, significantly raises the risk of infection and potential complications.
Tofajak-IN XR 11mg Tablet
259
MRP 300
13% off